Alpha Teknova (TKNO) Short term Debt (2023 - 2024)

Alpha Teknova's (TKNO) quarterly Short term Debt came in at $4.0 million in Q4 2024, up 60.01% on a QoQ basis from $2.5 million in Q3 2024.

Alpha Teknova (TKNO) Short term Debt (2023 - 2024) Analysis & Trends

Alpha Teknova (TKNO) has 2 years of Short term Debt data on file, last reported at $4.0 million in Q4 2024.

On a quarterly basis, Short term Debt changed N/A year-over-year to $4.0 million in Q4 2024; TTM through Dec 2024 was $4.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $4.0 million, changed N/A from the prior year.
Short term Debt for Q4 2024 stood at $4.0 million, up from $2.5 million in the prior quarter.
Over the last five years, Short term Debt for TKNO reached as high as $22.2 million in Q2 2023 and fell as low as $1.0 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Alpha Teknova	278.75 Mn	260.97 Mn	3.78 Mn

Download Data